Tissue microarrays for high-throughput molecular profiling of tumor specimens
暂无分享,去创建一个
J. Kononen | L. Bubendorf | G. Sauter | Anne Kallionimeni | M. Bärlund | P. Schraml | S. Leighton | J. Torhorst | M. Mihatsch | Olli-P. Kallionimeni
[1] H. Battifora. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[2] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[3] H. Battifora,et al. The checkerboard tissue block. An improved multitissue control block. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[4] D. Allred,et al. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance. , 1990, Archives of surgery.
[5] M. Fernö,et al. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. , 1991, British Journal of Cancer.
[6] D. Pinkel,et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[7] B. Dutrillaux,et al. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique , 1994, Genes, chromosomes & cancer.
[8] D. Slamon,et al. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression. , 1994, Cancer research.
[9] W. Kuo,et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. , 1994, Cancer research.
[10] P. Meltzer,et al. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection , 1994, Nature Genetics.
[11] L. Penland,et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.
[12] D. Slamon,et al. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. , 1996, Oncogene.
[13] Mybl2 (Bmyb) maps to mouse chromosome 2 and human chromosome 20q 13.1. , 1996, Genomics.
[14] R. Zeillinger,et al. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. , 1997, Cancer research.
[15] Persons Dl,et al. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization , 1997 .
[16] O. Kallioniemi,et al. Increased copy number at 17q22‐q24 by CGH in breast cancer is due to high‐level amplification of two separate regions , 1997, Genes, chromosomes & cancer.
[17] A. Marchetti,et al. Cyclin‐d1‐gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf1 immunohistochemical expression , 1997, International journal of cancer.
[18] T. Ried. Interphase cytogenetics and its role in molecular diagnostics of solid tumors. , 1998, The American journal of pathology.